Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.68 |
| ▸ | USP2 | O75604 | 3/20 | 0.68 |
| ▸ | POLB | P06746 | 2/20 | 0.68 |
| ▸ | ATM | Q13315 | 1/20 | 0.68 |
| ▸ | PLEC | Q15149 | 1/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | ALPL | P05186 | 1/20 | 0.54 |
| ▸ | ALPI | P09923 | 1/20 | 0.54 |
| ▸ | ALPG | P10696 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.46 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 6/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.44 |
| ▸ | CA2 | P00918 | 4/20 | 0.44 |
| ▸ | CDC25A | P30304 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13881039 | 0.88 | USP2 (0.64) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL14148863 | 0.87 | USP2 (0.60) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL14093812 | 0.86 | USP2 (0.59) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL19269681 | 0.86 | USP2 (0.49) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL8930410 | 0.85 | MEN1 (0.74) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL20411333 | 0.85 | MEN1 (0.60) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL15686673 | 0.83 | MEN1 (0.68) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL13078710 | 0.83 | USP2 (0.56) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL13314111 | 0.83 | USP2 (0.56) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL17385044 | 0.83 | USP2 (0.56) | MEN1KMT2AUSP2POLBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100209962-A1 | Tetranor PGDM: A Biomarker of PGD2 Synthesis In Vivo | THE TRUSTEES OF THE UNIVERSIT OF PENNSYLVANIA | 2010-08-19 | — | — | US | claimed |
| WO-2009043015-A1 | TETRANOR PGDM: A BIOMARKER OF PGD2 SYNTHESIS IN VIVO | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2009-04-02 | — | — | WO | claimed |
| US-20230167303-A1 | COLOR MATCHED AND BRIGHT FLUORESCENT MATERIALS COMPOSED OF SMALL-MOLECULE IONIC LATTICES | UNIVERSITY OF COPENHAGEN (DK) | 2023-06-01 | — | — | US | disclosed |
| EP-3604292-A1 | PROCESS FOR PREPARING FLUORESCEIN QUINOID FORM | Delmar Chemicals Inc. (CA) | 2020-02-05 | — | — | EP | disclosed |
| EP-3508586-A1 | METHOD AND KIT FOR DETECTING PATHOGENIC MICROORGANISM | Japan Science and Technology Agency (JP) | 2019-07-10 | — | — | EP | disclosed |
| EP-2778234-B1 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | PROMEGA CORP (US) | 2017-09-27 | — | — | EP | disclosed |
| US-8785682-B2 | Tetranor PGDM: a biomarker of PGD2 synthesis in vivo | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2014-07-22 | — | — | US | disclosed |
| EP-2204371-B1 | FLUORESCENT MOLECULE FROM A PROFLUOROPHORE | RIKEN (JP) | 2012-12-12 | — | — | EP | disclosed |
| WO-2012129128-A1 | FLUORESCENT DYES, FLUORESCENT DYE KITS, AND METHODS OF PREPARING LABELED MOLECULES | BIOTIUM, INC. (US) | 2012-09-27 | — | — | WO | disclosed |
| US-20110178281-A1 | Photocleavable Linker Methods and Compositions | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2011-07-21 | — | — | US | disclosed |
| US-20100234259-A1 | PERFUMES | CONOPCO, INC. D/B/A UNILEVER | 2010-09-16 | — | — | US | disclosed |
| WO-2009087033-A1 | GRANULES | UNILEVER PLC (GB) | 2009-07-16 | — | — | WO | disclosed |
| WO-2009047128-A1 | PERFORMANCE INGREDIENTS IN FILM PARTICLES | UNILEVER PLC (GB) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009047127-A1 | GRANULAR DETERGENT COMPOSITIONS WITH CONTRASTING LAMELLAR VISUAL CUES | UNILEVER PLC (GB) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009043015-A1 | TETRANOR PGDM: A BIOMARKER OF PGD2 SYNTHESIS IN VIVO | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009030601-A1 | IMPROVEMENTS RELATING TO FABRIC CONDITIONERS | UNILEVER PLC (GB) | 2009-03-12 | — | — | WO | disclosed |
| WO-2009030600-A1 | IMPROVEMENTS RELATING TO FABRIC CONDITIONERS | UNILEVER PLC (GB) | 2009-03-12 | — | — | WO | disclosed |
| WO-2009016123-A1 | IMPROVEMENTS RELATING TO PERFUMES | UNILEVER PLC (GB) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008141880-A1 | TRIPHENODIOXAZINE DYES | UNILEVER PLC (GB) | 2008-11-27 | — | — | WO | disclosed |
| WO-2008087031-A1 | POLYMERIC ANIONS/CATIONS | MERCK PATENT GMBH (DE) | 2008-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178281-A1 | Photocleavable Linker Methods and Compositions | NSUN2, RNGTT, METTL16 | MEN1 3299/4885KMT2A 332/4885USP2 1981/4885 |
| US-20100209962-A1 | Tetranor PGDM: A Biomarker of PGD2 Synthesis In Vivo | PTGDR, PTGDR2, PTGIR | MEN1 4155/4885KMT2A 3662/4885USP2 2095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.